amikacin has been researched along with transforming growth factor alpha in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xiao, WZ; Zhang, L | 1 |
| Daudet, N; Lenoir, M; Ripoll, C | 1 |
2 other study(ies) available for amikacin and transforming growth factor alpha
| Article | Year |
|---|---|
Adiponectin receptor agonist AdipoRon relieves endotoxin-induced acute hepatitis in mice.
Topics: Acute Disease; Animals; Apoptosis; Caspases; Disease Models, Animal; Galactosamine; Hepatitis; Hepatocytes; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Piperidines; Receptors, Adiponectin; Transforming Growth Factor alpha | 2019 |
Transforming growth factor-alpha-induced cellular changes in organotypic cultures of juvenile, amikacin-treated rat organ of corti.
Topics: Actins; Amikacin; Animals; Anti-Bacterial Agents; Bromodeoxyuridine; Cell Differentiation; Cell Division; Cell Survival; Epidermal Growth Factor; Hair Cells, Auditory; Immunohistochemistry; Insulin-Like Growth Factor I; Microscopy, Electron; Microscopy, Electron, Scanning; Nerve Degeneration; Nerve Regeneration; Neuroglia; Neurotoxins; Organ Culture Techniques; Rats; Rats, Wistar; Transforming Growth Factor alpha; Tretinoin | 2002 |